In patients with cervical dissection, there was no difference in rates of stroke, residual stenosis, or occlusion at 1 year in those treated with anticoagulants and those treated with antiplatelet ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Giving the P2Y12 inhibitor antiplatelet drugs ticagrelor or clopidogrel to noncritically ill, ...
Treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots. A new study has ...
Patients with newly diagnosed atrial fibrillation who take not only an oral anticoagulant (OAC) but also an antiplatelet face increased risks of stroke and bleeding at 1 year, according to an analysis ...
Blood thinners help prevent blood clots during and after surgery. There are two main types of blood thinners: anticoagulants and antiplatelets. Side effects of blood thinners can include bleeding and ...
Antithrombotic therapy aims to prevent blood clots and the serious damage they can cause. Types include anticoagulants like heparin, antiplatelets like aspirin, and emergency thrombolytics. Thrombosis ...
It’s unlikely that adding an antiplatelet agent to anticoagulation will increase the number of organ support-free days in critically ill patients with COVID-19, although it’s possible that survival in ...
Analysis of hospital registry data found that people who were hospitalized due to bleeding in the brain and who had taken multiple antiplatelet medications, or medications stronger than aspirin, were ...
Medically reviewed by Kristie Reed, PharmD Key Takeaways Natural blood thinners include spices like cayenne pepper and turmeric, and supplements such as vitamin E or fish oil.Cinnamon contains ...
Controversy exists over whether chronic antiplatelet therapy in patients with acute ischemic stroke is a contraindication to treatment with tissue plasminogen activator (tPA). Antiplatelets impair ...
Current treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots. A new Loyola ...